ArticleFrontiers in molecular biosciences2022

LyeTxI-b, a Synthetic Peptide Derived From a Spider Venom, Is Highly Active in Triple-Negative Breast Cancer Cells and Acts Synergistically With Cisplatin.

Joaquim Teixeira de Avelar Júnior et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.